Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Potential circulating biomarkers of circulating chemokines CCL5, MIP-1β and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection

Fig. 1

Serum levels of CCL5 and MIP-1β in different phases of CHB and HBV-related cirrhosis patients. a Serum levels of CCL5 in CHB patients at mild stage, moderate-to-severe stage, compensated HBV-related cirrhosis and decompensated HBV-related cirrhosis. b The serum levels of MIP-1β in CHB patients at mild stage, moderate-to-severe stage, compensated HBV-related cirrhosis and decompensated HBV-related cirrhosis. (*: P < 0.05, **: P < 0.01, ***: P < 0.001)

Back to article page